Advisor Net Financial, Inc Glaukos Corp Transaction History

Advisor Net Financial, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 14, 2021	SELL	$70.43 - $97.42 $22,819 - $31,564	-324 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$37.23 - $50.97 $4,653 - $6,371	-125 Reduced 27.84%	324 $16,000
Q2 2020 Aug 26, 2020	SELL	$28.78 - $46.83 $15,541 - $25,288	-540 Reduced 54.6%	449 $17,000
Q1 2020 May 14, 2020	SELL	$25.53 - $70.14 $23,385 - $64,248	-916 Reduced 48.08%	989 $31,000
Q4 2019 Feb 12, 2020	SELL	$54.18 - $65.64 $65,016 - $78,768	-1,200 Reduced 38.65%	1,905 $104,000
Q3 2019 Oct 23, 2019	SELL	$58.58 - $83.91 $43,935 - $62,932	-750 Reduced 19.46%	3,105 $194,000
Q2 2019 Jul 15, 2019	SELL	$63.59 - $78.71 $27,661 - $34,238	-435 Reduced 10.14%	3,855 $291,000
Q1 2019 May 14, 2019	SELL	$50.75 - $80.54 $44,254 - $70,230	-872 Reduced 16.89%	4,290 $336,000
Q4 2018 Feb 08, 2019	SELL	$52.18 - $67.93 $10,436 - $13,586	-200 Reduced 3.73%	5,162 $290,000
Q1 2018 May 08, 2018	BUY	$26.05 - $34.5 $115,193 - $152,559	4,422 Added 470.43%	5,362 $165,000
Q4 2017 Feb 27, 2018	BUY	$24.5 - $36.01 $23,030 - $33,849	940	940 $24,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.